Seelos Therapeutics, Inc. (NASDAQ:SEEL – Get Free Report)’s share price dropped 4.3% during trading on Monday . The stock traded as low as $0.22 and last traded at $0.22. Approximately 14,087 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 174,745 shares. The stock had previously closed at $0.23.
Seelos Therapeutics Price Performance
The company has a 50-day simple moving average of $0.53 and a 200 day simple moving average of $3.92.
About Seelos Therapeutics
Seelos Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD).
Featured Articles
- Five stocks we like better than Seelos Therapeutics
- What Are Some of the Best Large-Cap Stocks to Buy?
- Work and Play: Investing in the Rise of Bleisure Travel
- Learn Technical Analysis Skills to Master the Stock Market
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- How is Compound Interest Calculated?
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Seelos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seelos Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
